Spanish Red Biotech Pipeline

Amgen

carfilzomib

Type: Biodrugs/ Drugs
Therapeutic area: Blood and Lymphatic systems
Cancer
Indication: Recurrent or refractory acute lymphoblastic leukemia
Phase: 1Phase I in Spain